Literature DB >> 7002196

In vitro basal lamina formation may require non-epidermal cell living substrate.

D Woodley, M Régnier, M Pruniéras.   

Abstract

In an adult human epidermal cell culture system in which three different types of dermo-epidermal junctions could be observed, the in vitro synthesis of basement membrane and type IV collagen was studied with electron microscopy and indirect immunofluorescence via an antiserum to type IV collagen. Essentially, keratinocytes juxtaposed to non-living substrate did not produce either type IV collagen or an ultrastructural basement membrane, whereas both products were found at dermo-epidermal junctions composed of living keratinocytes juxtaposed to living dermis. This suggests that the microenvironment of the keratinocyte may influence the synthesis of junctional components.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002196     DOI: 10.1111/j.1365-2133.1980.tb07262.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  Transforming growth factor alpha induces collagen degradation and cell migration in differentiating human epidermal raft cultures.

Authors:  K Turksen; Y Choi; E Fuchs
Journal:  Cell Regul       Date:  1991-08

2.  Epithelial-mesenchymal interactions control basement membrane production and differentiation in cultured and transplanted mouse keratinocytes.

Authors:  A Bohnert; J Hornung; I C Mackenzie; N E Fusenig
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

3.  The influence of differing connective tissue substrates on the maintenance of adult stratified squamous epithelia.

Authors:  M W Hill; I C Mackenzie
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

4.  Basement membrane formation by malignant mouse keratinocyte cell lines in organotypic culture and transplants: correlation with degree of morphologic differentiation.

Authors:  J Hornung; A Bohnert; L Phan-Than; T Krieg; N E Fusenig
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.